⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 12, 2021Lupus

Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus

View Full Paper

Ask AI

Bookmark

Share

Authors

RFRichard FurieNorthwell Health EMEric F. MorandNovartis (Switzerland)AAAnca AskanaseColumbia University Irving Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Furie et al. (2021) studied this question.

synapsesocial.com/papers/6a93a31b2cf12ee0be69749a https://doi.org/10.1177/09612033211014267

View Full Paper

Ask AI

Bookmark

Share